Healius Ltd
ASX:HLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Healius Ltd
Cost of Revenue
Healius Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Healius Ltd
ASX:HLS
|
Cost of Revenue
-AU$212.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Cost of Revenue
-AU$1.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cost of Revenue
-AU$34.1m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cost of Revenue
-AU$128.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Cost of Revenue
-AU$69.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
INOVIQ Ltd
ASX:IIQ
|
Cost of Revenue
-AU$120.4k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Healius Ltd
Glance View
Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales and currently employs 11,000 full-time employees. The firm operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The firm also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.
See Also
What is Healius Ltd's Cost of Revenue?
Cost of Revenue
-212.3m
AUD
Based on the financial report for Dec 31, 2025, Healius Ltd's Cost of Revenue amounts to -212.3m AUD.
What is Healius Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-3%
Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Healius Ltd have been 5% over the past three years , 1% over the past five years , and -3% over the past ten years .
